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Amplified antimicrobial action of chlorhexidine encapsulated in 
PDAC-functionalized acrylate copolymer nanogel carriers 
Mohammed J. Al-Awady,a,b Paul J. Weldrick,a,c Matthew J. Hardman,c Gillian M. Greenway,a and 
Vesselin N. Paunova*  
We have developed and tested a novel functionalised nanocarrier for chlorhexidine (CHX) which provides a very strong 
enhancement of its antimicrobial action. The nanocarrier was based on lightly-cross-linked acrylate copolymer nanogel 
particles loaded with CHX followed by a surface functionalisation with the cationic polyelectrolyte 
poly(diallyldimethylammonium chloride (PDAC). We explored the antimicrobial effect of the PDAC-coated CHX-loaded 
nanogel carriers on E. coli, S. auresus, C. cerevisiae and C. reinhardtii and discovered that it is much higher than that of 
solution with equivalent overall concentration of free CHX. Our experiments also showed a marked increase of the cationic 
CHX-loaded nanocarriers antimicrobial action on these microorganisms at shorter incubation times compared with the non-
coated CHX-loaded nanogel particles at the same CHX concentration and other conditions. We attribute the increase in the 
antimicrobial activity of the cationically-functionalised nanogel carrier to its electrostatic adhesion to the microbial cells 
walls which allows much higher CHX concentration to be delivered directly onto the cell surface. The results of this study 
can be used for development of novel more efficient antialgal, antifungal and antbacterial formulations based on cationically 
functionalised nanogels. Our method can also be used for boosting the effect of other cationic antimicrobial agents by 
encapsulating them in cationically-functionalised nanogel carriers. This nanotechnological approach could lead to 
developing more effective antimicrobial and disinfecting agents, dental formulations for plaque control, wound dressings, 
antialgal/antibiofouling formulations and novel antifungal agents. 
 
Introduction 
Nanocarrier-based drug delivery is a rapidly evolving area aimed 
at releasing and maintaining optimal concentrations of 
nanoparticle-encapsulated therapeutic agents to the 
specifically target infected tissues, tumours, etc. while reducing 
their side effects on normal tissues.1,2 Commonly used 
nanocarriers for drug delivery include liposomes, polymeric 
micelles and dendrimers, artificial DNA structures, and 
biodegradable scaffolds.2 Nanogels are internally cross-linked 
particles of hydrophilic polymer which may contain sulphate, 
hydroxyl and carboxyl ionisable groups in polymer chains.3 Such 
physically or chemically cross-linking polymer networks can 
swell in a aqueous suspension due to water absorption.4-5 
Nanogels have good biocompatibility which is crucial for 
avoiding inflammatory responses and other side effects.6-8  
Chlorhexidine gluconate (CHX) is a cationic bisbiguanide and 
consists of two symmetric 4-chlorophenyl rings and two 
biguanide groups linked by a central hexamethylene chain. CHX 
digluconate salt is easily soluble in water9,10 and is frequently 
used as a chemotherapeutic agent especially against oral 
diseases due to its wide spectrum of activity against yeasts, 
Gram-positive, Gram-negative bacteria and many anaerobic 
pathogens.11 The CHX cation binds to anionic groups on the 
bacterial surface such as phosphate groups of teichoic acid in 
Gram-positive and lipopolysaccharide in Gram-negative 
bacteria and disrupts their membrane integrity.12 This leads to 
leakage of the cell constituents and eventually to the cells 
death.13 CHX is one of the most effective antimicrobial agents 
for dental plaque control.14-16 A recent and practical release 
system is the combination of microfibrillated cellulose (MFC) 
and β-cyclodextrin (β-CD) that produces a large dosage of 
chlorhexidine gluconate over a prolonged period of time, MFC 
is known for its burst action whilst β-CD is a slow releasing drug 
delivery agent.17 Mesoporous silica nanoparticles have been 
recently used as a CHX release system that effectively targets 
planktonic and biofilm modes of oral pathogens.18 Silica sub-
micrometer size capsules impregnated with 2% CHX and coated 
with sodium alginate and chitosan have been reported as a 
better root canal drug against Enterococcus faecalis which is a 
major cause of root canal infections.19 Antimicrobial strategies 
combining polymer science and nanotechnology have attracted 
tremendous interest in the last decade because of their great 
potential in many applications.39,40 
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Figure 1. The schematic diagram for the encapsulation of chlorhexidine (CHX) ions from 
chlorhexidine digluconate) into a Carbopol nanogels by using swelling/deswelling cycle 
of the nanogel in the basic (pH 8) and acidic (pH 5.5) medium, respectively. The CHX-
loaded nanogel was surface-functionalised with a cationic polyelectrolyte (PDAC). The 
chemical formulas of the carbomer nanogel (partially crosslinked polyacrylic acid NPs), 
the PDAC and the chlorhexidine digluconate are also presented. 
Poly (dl-lactic-co-glycolic acid) (PLGA) microparticles containing 
chlorhexidine (CHX) free base, chlorhexidine digluconate (CHX-
DG) with methylated--cyclodextrin (MBCD) and 
hydroxypropyl--cyclodextrin (HPBCD) have recently been 
explored against periodontitis causing bacteria (P. gingivalis 
and B. forsythus).20  
Wound treatment needs molecules that both improve healing 
and control infection. Poly (lactic-co-glycolic acid) (PLGA) 
microspheres based drug delivery system for CHX was recently 
reported which simultaneously transports platelet-derived 
growth factor (PDGF)-BB, a hydrophilic protein known to 
stimulate wound healing, and CHX for infection treatment. This 
can improve healing and decrease bacteria levels in an infected 
wound model.21 Positively charged CHX-loaded Poly(ϵ-
caprolactone) (PCL) nanocapsules, prepared by interfacial 
polymer deposition /solvent displacement were also reported 
with good encapsulation efficiency.22 The study described a 
sustained release of CHX from PCL nanocapsules by mediating a 
more direct and prolonged contact between the nanocapsules 
and  bacteria, skin surface, and skin follicles and provided a 
prolonged ex vivo topical antimicrobial activity against 
Staphylococcus epidermidis.22  
Antimicrobial nanoparticles (NPs) of hexametaphosphate salt of 
chlorhexidine (CHX) have been recently produced by co-
precipitation of aqueous solutions of CHX digluconate and 
sodium hexametaphosphate. These NPs adhered well on glass, 
titanium, and an elastomeric wound dressing surfaces and 
showed a slow release of CHX over a period of at least 50 days 
proving effective against methicillin-resistant S. aureus (MRSA) 
and P. aeruginosa in both planktonic and biofilm conditions.23  
Recently, nanocarriers formulated from biodegradable 
materials attracted a lot of attention following concerns about 
the post-use fate of the nanocarrier formulations.24,25 Al-Awady 
et al.26 demonstrated that the nanotoxicity of polyelectrolyte-
coated TiO2NPs changes with the surface charge with those 
particles with a cationic outer layer (or bare titania 
nanoparticles at acidic pH) being much more toxic than the ones 
with an outer layer of anionic polyelectrolyte. A range of other 
antimicrobial particles have recently been developed which use 
the same approach for delivery of therapeutic alkaloids.27 
Frangville et al.28 developed biodegradable lignin nanoparticles 
which showed no measurable toxicity against proxy organisms 
like yeast and microalgae. Recently, these were utilised for 
silver ion delivery system based on Ag+-loaded lignin 
nanoparticles which were further coated with cationic 
polyelectrolyte.29,30 The produced silver ion delivery vehicles 
proved to more efficient antimicrobial agents for a range of 
bacteria than equivalent concentrations of silver in metallic 
silver nanoparticles.  
In this study, we push forward these ideas to encapsulate CHX 
in nanogel particles based on a partially cross-linked acrylate 
copolymer for antibacterial, antifungal and anti-algal 
applications. We explore the stability of the CHX-loaded 
Carbopol nanogel particles (CLC), the CHX encapsulation 
efficiency, the controlled release of encapsulated CHX-cations 
and the antimicrobial activity of the formed CHX-nanogel 
complexes before and after surface functionalisation with 
cationic polyelectrolyte. Carbopol Aqua SF1 is an aqueous 
dispersion approximately 30% w/v of a lightly cross-linked and 
highly hydrophilic acrylate nanogel which does not exhibit 
toxicity against a range of microorganisms and does not trigger 
inflammatory reactions in animal organs.31  
Figure 1 explains the encapsulation steps of CHX into the 
nanogel and the surface functionalisation of the produced 
nanoparticles with a cationic polyelectrolyte. The retention of 
the CHX in the core of the nanogel is based on electrostatic 
interaction with non-covalent bonding to ensure further release 
of the antimicrobial agent upon incubation of the loaded 
nanogel particles with the tested microorganisms.  
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Figure 2. (A) The average particle diameter of Carbopol Aqua SF1 as a function of pH. (B) TEM image of CHX-loaded collapsed Carbopol at pH 5.5 which shows the physical size of the 
produced collapsed nanogel particles after evaporation of the aqueous media. The encapsulation was achieved through adjusting Carbopol suspension to pH 8, addition of CHX 
solution to form chlorhexidine-loaded swollen Carbopol. The formed suspension was adjusted to pH 5.5 to “collapsed” CHX loaded Carbopol nanogel (CLC). (C) Photograph of bare 
Carbopol Aqua SF1 suspension, chlorhexidine solution, CHX-loaded Carbopol at pH 8 and pH 5.5 along with a centrifuged CLC particles and the CLC suspension after re-dispersing it 
at pH 8. (D) Stability of PDAC-coated Carbopol at pH 5.5.  A Malvern Mastersizer was used to measure the zeta potential was measured at time intervals at a refractive index of 1.450.  
Each value represents a triplicate with ± SD. (E) The particle hydrodynamic diameter and (F) the mean zeta potential of the CLC particles as a function of the CHX concentration at 
different concentrations of the Carbopol Aqua SF1. 
 
 
Here we studied the antibacterial, anti-fungal and antialgal 
action of CLC on four proxy microorganisms, E. coli, S. aureus, S. 
cerevisiae and C. reinhardtii respectively. We also study the CHX 
release kinetics and the boost of its antimicrobial action after 
coating of the CLC nanocarriers. We show that this strategy can 
strongly amplify the antimicrobial action of CHX compared to 
equivalent concentration of free CHX. This versatile and 
inexpensive nanocarrier can potentially be used for many other 
cationic antimicrobial agents and antibiotics to provide a boost 
of their action or minimize their overall concentration. 
Materials and Methods 
Materials 
We used Carbopol Aqua SF1 nanogel as an aqueous 
suspension (30 wt%) as supplied by Lubrizol, USA. Fluorescein 
diacetate (FDA, 98%) for cell viability assays and 
poly(diallyldimethylammonium chloride) (PDAC) was supplied 
from Sigma Aldrich, UK. Chlorhexidine digluconate (98%) and 
was delivered by Fluka, UK. Chlamydomonas Reinhardtii (cc-124 
strain, was sourced from Flickinger’s group at North Carolina 
State University, USA). It is a microalgae culture which was 
grown in Tris-Acetate-Phosphate (TAP) culture medium with an 
incubation temperature of 30 oC. The culture media for C. 
reinhardtii consisted of TAP salts (NH4Cl; MgSO4.7H2O and 
CaCl2.2H2O), phosphate buffer solution (PBS) and Hunter’s trace 
elements solution (EDTA disodium salt, ZnSO4.7H2O, H3BO3, 
MnCl2.4H2O, CoCl2.6H2O, CuSO4.5H2O, FeSO4.7H2O, 
(NH4)6Mo7O24.4H2O, all purchased from Sigma-Aldrich, UK. The 
microalgae batch was grown in the TAP media at pH 7 while 
being illuminated for 72 hours with a white luminescent lamp 
with a light intensity of 60 W m-2 under constant stirring with a 
magnetic stirrer.32,33 The stock cultures of C. reinhardtii which 
were used for testing were with typical concentration 4  105 
cells per mL determined by automatic cell counter (Cellometer 
Auto X4) and the E. coli bacterial culture stock was with 
approximately 5  107 cells per mL. Deionised water purified by 
reverse osmosis and ion exchange from a Milli-Q water system 
(Millipore, UK) was used in all our studies. Its surface tension 
was 71.9 mNm-1 at 25°C, with measured resistivity of 18 MΩ cm. 
Preparation of CHX-loaded Carbopol nanogel particles (CLC) 
The method is based on a pH induced swelling-deswelling cycle. 
A 0.1 wt.% aqueous dispersion of the nanogel was prepared by 
weighing 0.1 g of stock solution of the Carbopol Aqua SF1 and 
dispersing it in 75 mL Milli-Q water, this was then adjusted to 
pH 8 using 3 drops of 0.25 M NaOH.  An aliquot of 0.1 wt. % of 
chlorhexidine digluconate was then added dropwise to the 
Carbopol Aqua SF1 solution to prepare a 0.1 wt. % chlorhexidine 
in 0.1 wt. % nanogel dispersion. CHX-Carbopol solutions was 
reduced to pH 5.5 using drops of 0.25 M HCl whilst being stirred 
for 30 minutes.  Solutions was the centrifuged at 8500 rpm for 
30 minutes.  
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Figure 3. The Fourier Transform-IR spectrum of Carbopol Aqua SF1 (A), chlorhexidine (B), CLC (C) and PDAC (D). These materials were dried and mixed with excess of KBr pellets to 
prepared KBr discs for each of Carbopol nanogel, CHX and CLC which in turn were scanned individually from 400 cm-1 to 4000 cm-1. (E) Thermal Gravimetric Analysis (TGA) and 
Differential Thermal Analysis (DTA) of chlorhexidine (red line), Carbopol Aqua SF1 (blue line) and CLC (black line) from 100 oC to 900 oC at 10 °C/min in air atmosphere with purge 
rate of 10 mL min-1. (F) The UV/vis absorbance spectrum of 0.01 wt% Carbopol Aqua SF1 (Blue line), 0.007 wt% CHX (Orange line) and 0.006 wt% CLC (Black line). (G) The percentage 
of CHX release as a function of time for 0.15 wt% CHX-loaded in 0.1 wt% Carbopol (CLC). The experiment was conducted using 10 K MWCO dialysis bag filled up with 50 mL of CLC 
suspension. The whole dialysis bag was dipped in a beaker filled with 500 mL of either acetate buffer solution at pH 5.5 or phosphate buffer at pH 7.5. The CHX concentration in the 
buffer was monitored spectroscopically and calculated from Figure 2D. 
 
The precipitate was washed twice with Milli-Q water and the 
supernatant discarded.  20 mL of Milli-Q water was added to the 
precipitate, the pH was gradually increased to 8 using drops of 
0.25 M NaOH and the solution stirred overnight.  The following 
morning the pH of the CHX-Carbopol (CLC) solution was reduced 
to 5.5 using acetate buffer. We measured the size distribution 
and zeta-potential of a range of solutions prepared by mixing 
aqueous solutions of different concentrations of CHX and the 
nanogel suspension. A Malvern Mastersizer was used to 
measure the CLC particle hydrodynamic diameter at a refractive 
index of 1.450. The pH was adjusted with 0.25 M HCl or 0.25 M 
NaOH solutions.  Each value represents the average of a triple 
replicate with ± S.D. 
Release kinetics of CHX from CLC 
We investigated the percentage of in vitro CHX released using 
aliquots of equivalent concentrations of CHX-loaded 0.1 wt% 
Carbopol nanogel. This formulation was optimized in terms of 
stability. The particle size and zeta potential of the CHX-loaded 
nanogel particles at pH 5.5 were 135 nm and -30 mV, 
respectively. The CHX-loaded nanogel suspension was placed 
into a dialysis cassette (10K MWCO, Thermo Fisher, UK) which 
released the CHX leaching from the nanogel through the 
membrane. The dialysis device was placed into a beaker which 
was already pre-filled with: (i) an acetate buffer solution at pH 
5.5 or (ii) a phosphate buffer at pH 7.5 in order to monitor the 
amount of released CHX at a specific pH. The concentration of 
the released CHX was measured using UV-Visible 
spectrophotometer. All experiments were carried out in 
triplicate and the percentage of cumulative drug release was 
calculated. 
Surface functionalization of CLC with PDAC 
We used the cationic polyelectrolyte PDAC to reverse the 
surface charge of the Carbopol Aqua SF1 nanogel particles from 
negative to positive which promotes adhesion to the microbial 
cell walls. PDAC solutions with a range of different 
concentrations (0.001-0.01 wt%) were mixed separately with a 
fixed concentration of the nanogel (0.1 wt%) at a pH adjusted in 
the range of 4.75-5.00 using acetate buffer with the final 
volume of the suspension being 10 mL. The zeta potential was 
measured for each sample to find out the optimum 
concentration of both the PDAC and the nanogel which in turn 
give stable suspension. Typically, a 1.10 mL aliquot of 0.2 wt% 
PDAC solution was rapidly added to a suspension of 10 mL of 
the CLC suspension with vigorous shaking and then diluted to 
20 mL to form PDAC-coated 0.005 wt% CHX-loaded 0.1wt% 
Carbopol Aqua SF1 nanogel dispersion (PDAC-coated CLC). The 
resulting solution was used as a stock to study its antimicrobial 
effect on C. reinhardtii, S. cerevisiae, E. coli and S. aureus. 
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Figure 4. TEM images of sectioned C. reinhardtii cells (A) as control sample without prior treatment and (B) after incubation with 0.1% Carbopol Aqua SF1 nanogel followed by 
washing, negative staining and embedding in acrylic resin. The cell viability of C. reinhardtii (C) and E. coli (D) incubated in aqueous suspensions of varying concentrations of the 
nanogel at 25 oC at pH 5.5 for different periods of time. The cell viability was tested with FDA live/dead assay for C. reinhardtii and Promega CellTiter-Glo® assay for E. coli, respectively.  
 
Cytotoxicity test of the non-coated Carbopol nanogel particles 
A cell viability assay was performed to determine the 
cytotoxicity of the Carbopol Aqua SF1 nanogel on both of C. 
reinhardtii and E. coli. A 0.3 wt% dispersion of Carbopol Aqua 
SF1 was prepared in a 100 ml volumetric flask by dilution of an 
aliquot of the supplied stock with milli-Q water. The pH was 
adjusted to 5.5 using acetate buffer. 5 mL aliquots of the cell 
suspension were washed from the culture media and incubated 
with a series of 5 mL aliquots of the nanogel dispersion of 
concentrations (0.01-0.15 wt%) and tested at different 
incubation times. The control sample was treated in the same 
way without incubation with the nanogel. The cell viability was 
examined as described below. 
Testing the effect of PDAC-coated CLC on C. reinhardtii  
C. reinhardtii was cultured in media containing 2.42 g Tris, 25 
mL TAP salts, 375 μL phosphate solution, 1000 μL Hunter’s trace 
element, and 1000 μL glacial acetic acid per 1 L of Milli-Q water.  
A 50 mL aliquot was removed from the culture for viability 
testing. This was centrifuged at 3000 rpm for 3 minutes to pellet 
the cells, the supernatant was discarded and the cells re-
dispersed in 50 mL of fresh Milli-Q water by gentle shaking.  
Fluorescein diacetate (FDA) is a non-polar esterified compound 
which easily diffuses through the cell membranes. If the cell is 
viable and its membrane is intact the hydrolysis of the non-
fluorescent precursor (FDA) by intracellular esterase leads to 
accumulation of fluorescein. We used 0.5% w/v FDA dissolved 
in acetone. 20 µL of this solution was used per mL of cell sample. 
The tube with the mixture was shaken for 10 minutes using a 
vortex at 1500 rpm in dark conditions to avoid the 
photobleaching of the produced fluorescein inside the viable 
cells. This was repeated for cells incubated at room 
temperature for 1 and 2 hours.  The cell viability was measured 
using a Cellometer Auto X4 cell counter. 20 μL of the sample 
was loaded into a disposable plastic counting chamber and the 
fluorescing (viable) and non-fluorescing (non-viable) cells 
measured using bright field and fluorescent microscopy 
imaging. This was repeated three times to obtain an average.  
When a cell viability above 85% was measured then the original 
50 mL stock sample was used for further testing.  5 mL aliquots 
were of this stock were mixed with 5 mL aliquots of various 
treatments for 0 hours (5 minutes), 1 hour and 2 hours, 
respectively. We tested the C. reinhardtii cell viability in the 
following solutions:  
(i) 0.005 wt% PDAC;  
(ii) 0.005 wt% PDAC-coated 0.1 wt% Carbopol (no CHX);  
(iii)  0.1 wt% CHX (chlorhexidine digluconate);  
(iv) 0.1 wt% encapsulated CHX in 0.1% Carbopol (CLC); 
(v) 0.005 wt% PDAC - coated 0.1 wt% CHX-loaded in 0.1 % 
Carbopol (PDAC-coated CLC).  
After incubation of the microalgae cell sample with these 
solutions, an aliquot was again centrifuged at 3000 rpm for 5 
minutes and excess treatment washed away.  The cells were re-
suspended in 1 mL of Milli-Q water. C. reinhardtii cell viability 
was measured by using 20 μL of this cell suspension in a 
Cellometer Auto X4. 
Testing the effect of PDAC-coated CLC on S. cerevisiae 
S. cerevisiae was cultured in media containing 20 g peptone, 10 
g yeast extract, 20 g D-glucose per 1000 mL Milli-Q water.  0.01 
g of dried S. cerevisiae was added per 100 mL of media.  A 50 
mL aliquot was removed from the culture for viability testing.  
This was centrifuged at 3000 rpm for 3 minutes to pellet the 
cells, the supernatant was discarded and the cells dispersed in 
50 mL of fresh Milli-Q water by gentle shaking.  1 mL of washed 
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S. cerevisiae sample was pipetted into a sample tube and 20 μL 
of the FDA stock solution in acetone was added and the mixture 
was incubated at room temperature in dark conditions. This was 
repeated for cells incubated at room temperature for 1 hour 
and 2 hours. The viability was measured using a Cellometer 
Auto X4 cell counter as described previously for C. reinhardtii.   
Testing the effect of PDAC-coated CLC on E. coli 
We prepared 300 mL of E. coli cultured in LB media.  50 mL was 
aliquoted and subsequently centrifuged at 3000 rpm for 5 
minutes. The supernatant was discarded, and the cell pellet re-
suspended in 50 mL of milli-Q water.  Various concentrations of 
treatment formulations were created in 5 mL aliquots (see 
Table 1) by dilution from the stock solution of 0.0025 wt% PDAC 
– coated 0.05 wt% CHX-Carbopol.  5 mL of the E. coli culture 
(redispersed in Milli-Q water) was added to 5 mL of the various 
formulations and gently shaken by hand to mix.  The E. coli and 
formulation aliquots (total 10 mL) were incubated for 0 hours (5 
min), 1 hour and 2 hours, respectively under the same 
conditions as for the original E. coli culture. Post incubation the 
E. coli and treatment aliquot was centrifuged at 3000 rpm for 5 
minutes and the supernatant discarded (removing access CHX 
and halting the cell viability experiment). The cell pellet was 
resuspended in 1 mL of Milli-Q water by gentle shaking.  100 μL 
aliquot of each sample was pipetted into white opaque 96 well 
plate and immediately afterwards 100 μL Promega Cell Titer-
Glo® luminescent cell viability assay reagent was added. The 
mixture of sample and reagent was equilibrated at room 
temperature for 30 minutes as stated in the manufacturer’s 
protocol. The luminance was measured using a Thermo 
Scientific Fluroskan Ascent FL. 
Protocol for SEM imaging of the treated cells 
The microbial cells to be studied were removed from 
their culture media by washing PBS buffer, adhered to Aclar 
film, and then fixed in 2.5 wt% glutaraldehyde in 0.1M 
cacodylate buffer pH 7.2 for 2 hours at room temperature. 
Then, they were washed three times with cacodylate buffer and 
fixed in 1 wt% osmium tetroxide in cacodylate buffer for 1 hour. 
Finally, the cells were washed with cacodylate buffer, 
dehydrated in a series of ethanol-water solutions with 
decreasing water content and then dried using liquid carbon 
dioxide at its critical point.   
 
MIC and MBC of CHX and PDAC-coated CLC on S. aureus  
The following protocol was used to determine the Minimal 
Inhibitory Concentration (MIC) and the Minimal Bactericidal 
Concentration (MBC) of CHX and PDAC-coated CLC on S. aureus. 
A negative control of 100 μL of MHB (Muller Hinton Broth) was 
added to the first line of wells of a 96 well plate. 50 μL of MHB 
was added to the treatment wells and the positive bacteria 
control wells. A stock solution of CHX and PDAC-coated CLC was 
created in fresh MHB to a total volume of 10 mL.  50 μL of this 
formulation was added to the first line of treatment wells, and 
serial diluted 1:2 across the 96 well plate, ensuring it was mixed 
by pipetting up and down within each well. An overnight culture 
of S. aureus was diluted into sterilised 0.85% saline until an 
absorbance reading of between 0.08-0.12 at 625 nm was 
obtained on a spectrophotometer (0.5 Mcfarland Standard). 
The saline diluted bacteria was diluted further 1:150 into MHB 
(10 mL MHB + 66.67 μL of bacteria in saline solution) yielding a 
10 mL stock containing 5x105 – 1x106/mL cells.  50 μL from this 
bacteria stock was added to each treatment and positive 
bacteria control wells, seeding with 2.5  104 – 5  104 cells per 
well. Each well contained a final volume of 100 μL with 
decreasing concentrations of treatment on equal amounts of 
bacteria.  The plate was incubated for 20 hours at 37oC. After 
incubation, 20 μL of resazurin solution was added to each well, 
and the plate incubated for 3 hours at 37oC. The resazurin 
solution was formulated by dissolving resazurin powder into 
DPBS at 0.15 mg/mL. The plate was then colometrically 
measured at 570 nm excitation / 595 nm emission. The reading 
from the negative control wells was subtracted from the 
remaining wells to remove background absorbance.  The MIC 
was determined by from the lowest concentration treatment 
which inhibited growth. 
 
S. aureus time kill assay 
Antimicrobial activity of 0.1% free CHX and 0.1% CHX-
encapsulated in CLC after PDAC-functionalisation was tested 
against S. aureus (ATCC number 29213).  An overnight culture 
of S. aureus was diluted in MHB to a population of 5  105 – 1  
106 CFU/mL, and treated with antimicrobial formulations at 
37oC.  At selected time points 100 μL aliquots were removed, 
neutralised in Dey-Engley Broth and serially diluted for colony 
enumeration. The control received no treatment. This was 
added to the 5 mL bacterial sample creating a 10 mL aliquot 
containing 5x105 – 1x106/mL CFU and 0.1 wt% CHX in 0.005 wt% 
PDAC-coated CLC encapsulated chlorhexidine. The three 
aliquots of were placed into a shaking rack and incubated at 
37oC for 24 hrs.  100 μL (from the 10 mL test sample yields 5  
104 – 1  105 CFU/100 μL) of each of the aliquots were removed 
at specific time points, 0 hr, 30 min, 1, 2, 3, 6 and 24 hours.  The 
100 μL sample that was removed was serial diluted in 
neutralising Dey-Engley broth and plated onto agar at 102, 103, 
104, 105, 106, 107 dilutions depending on the time point (100 μL 
spread on agar x 3 repeats). The plates were incubated at 37 oC 
and enumerated 24 hours later. 
Results and Discussion 
Encapsulation of CHX into Carbopol Aqua SF1 nanogel 
We used a pH mediated swelling/deswelling method to 
encapsulate CHX cations in the core of the acrylate copolymer 
nanogel particles. Figure 2A shows the increase of the nanogel 
particle size with the increase of pH. Here we enclose details of 
the swelling behaviour of the Carbopol nanogel before and after 
loading with CHX. The non-loaded Carbopol nanogel particles 
have an average diameter of about 100 nm at a pH below 6.8 
and swells sharply to approximately 330 nm just above pH 7.  
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Figure 5. All data on this figure characterise the non-loaded Carbopol nanogel after coating with PDAC. (A) The average particle hydrodynamic diameter and zeta-potential of PDAC-
coated Carbopol Aqua SF1 suspension as a function of the PDAC concentration which were obtained by mixing solutions of varying concentration of PDAC with 0.1 wt% Carbopol 
nanogel. The cytotoxic effect of PDAC-coated Carbopol Aqua SF1 particles at different ratios of PDAC-to-Carbopol on (B) C. reinhardtii and (C) E. coli for up to 2 hours at 25 oC.  
 
 
The swelling/deswelling feature of the Carbopol microgel was 
exploited for the purposes of development of CHX delivery 
system. This microgel was therefore used to encapsulate 
chlorhexidine digluconate with the aim of targeted delivery to 
microbial cells. The size of the collapsed Carbopol nanogel 
particles was also confirmed by TEM imaging (Figure 2B). Above 
pH 7 the Carbopol Aqua SF1 nanogel particles swell as the 
carboxyl groups of the acrylate-copolymer are deprotonated to 
a higher degree which allows the CHX cations to interact and 
bind with them electrostatically. This was then followed by a pH 
drop to 5.5 which causes shrinkage of the CHX-loaded nanogel 
particles (CLC), which are then centrifuged to separate them 
from the free CHX. The pH of the CLC suspension was raised to 
pH 8 so that the particles in the pellet swell and re-disperse 
again. This was followed by de-swelling the redispersed 
particles at pH 5.5 using acetate buffer. This procedure yielded 
fully dispersed and stable suspension of CHX-loaded Carbopol 
nanogel. Figure 2C illustrates the visual appearance of the 
nanogel suspension at different stages of the loading with the 
CHX and their successful re-dispersing in water.  
Effect of the CHX concentration on the CLC nanocarrier stability 
After encapsulation of the CHX in the swollen nanogel particles 
and their shrinking at pH 5, the size of the loaded (CLC) particles 
depends on both the initial CHX and Carbopol concentration. 
The effect of different concentrations of chlorhexidine on the 
colloidal stability of the 0.1 wt% Carbopol Aqua SF1 was 
investigated. Figure 2E shows the increase of the nanogel 
particle size after loading with CHX. The particle size increase is 
an indication for partial aggregation at high CHX-to-Carbopol 
ratio. Therefore we choose to work at 0.1 wt% Carbopol initial 
concentration and a moderate CHX-to-Carbopol ratio as it only 
marginally increased the size of the collapsed CLC nanogel 
particles at pH 5.5 across the full range of CHX concentrations 
(Figure 2E). At higher CHX concentrations (0.1 wt%), the average 
hydrodynamic diameter of the collapsed CLC particles appeared 
to be 135 nm without significant particle aggregation. The 
loading of the nanogel particles with CHX did not seem to 
significantly change the zeta potential of the collapsed CHX 
loaded nanogel (CLC) as a function of the CHX initial 
concentration, which remained negative in the range -(25-30) 
mV (Figure 2E).  
Spectroscopy studies of the CLC nanogel particles 
FTIR spectra were obtained for Carbopol, CHX, CHX-loaded 
Carbopol (CLC). For Carbopol (Figure 3A), a characteristic peak 
was seen in the range 3300-3500 cm-1 due to the stretching 
vibrations of O-H and intermolecular hydrogen bonding. The 
strong peak between 2850 cm-1 and 3000 cm-1 is due to the 
stretching vibration band of the aliphatic C-H bond. The peak in 
the range 1670 – 1750 cm-1 is attributed to a strong vibration 
band of carbonyl stretching (C=O) while the two variable peaks 
at 1400 – 1490 cm-1 were assigned to the stretching vibration 
band of the carbonyl bond (C-O). The peak appearing from 1000 
– 1300 cm-1 was attributed to the coupling between in-plane O-
H bending and C-O stretching of neighbouring carboxyl 
groups.34,35 The spectrum of CHX (Figure 3B) is characterized by 
the main stretching vibrations from 3300 cm-1 to 3500 cm-1 for 
the N-H group. The bands at 2850 cm-1 to 3000 cm-1 are 
stretching vibration bands due to the aliphatic C-H group, while 
the peak at 1672 cm-1 relates to the stretching vibration band of 
the aliphatic C=N group which is considered as a characteristic 
peak of CHX. There are also a peaks at wavelengths from 1450 
cm-1 to 1550 cm-1  which are assigned to C=C group in the 
aromatic ring and at 1251 cm-1 which relates to the stretching 
vibration frequency of aliphatic amine (C-N) group.36-38 Figure 
3C shows the FTIR spectrum of CLC. The broad absorption band 
at 3435 cm-1 can be allocated to the O-H groups for Carbopol 
while the band at 3364 cm-1 for the N-H group for chlorhexidine. 
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Figure 6. SEM images of C. reinhardtii cells with (A) being the control sample of untreated C. reinhardtii, (B) and (C) samples of C. reinhardtii after incubation in a suspension of 0.005 
wt% PDAC-0.0225 wt% CHX-Carbopol Aqua SF1 suspension for 1 hour. (D) The viability of C. reinhardtii cells after timed exposure to antimicrobial formulations of PDAC-coated CLC 
at different concentrations for various time points (0, 1, 2 hours). The solutions are prepared by gradual dilution of a stock of 0.005 wt% PDAC-coated 0.1 wt% CHX loaded in 0.1 wt% 
Carbopol (CLC). (E) The viability of C. reinhardtii cells after timed exposure to antimicrobial formulations in Milli-Q water for various time points (0, 1, 2 hours). The graph compares 
the anti-algal activity of 0.005 wt% PDAC, 0.005 wt% PDAC coated Carbopol Aqua SF1 nanogel, 0.1 wt% CHX, 0.1 wt% CLC and 0.005 wt% PDAC-coated 0.1 wt% CLC. The cell viability 
was tested with FDA live/dead assay in a Cell counter. 
The frequencies at 1653 cm-1 and 1734 cm-1 were noticed as 
principal characteristic bands for CHX-loaded Carbopol Aqua 
SF1 as they represent the vibration bands of the aliphatic C=N 
group for CHX and the carbonyl group (C=O) for Carbopol, 
respectively. The FTIR spectra therefore confirm that the CHX 
was successfully encapsulated into Carbopol Aqua SF1 nanogel. 
This result were also supported by TGA (Figure 3E) and the UV-
vis spectrum data for CLC (Figure 3F). The UV-vis absorption 
spectrum of Carbopol Aqua SF1, CHX and CLC indicate the 
physical conjugation between Carbopol Aqua SF1 and CHX. It 
can be seen that Carbopol Aqua SF1 (blue line) absorbs in the 
UV region between 250 nm to 200 nm. CHX (orange line) has 
two broad absorbance peaks in the UV region, one at 254 nm 
and another at 233 nm. The CLC (black line) exhibited two 
substantial peaks at 264 nm and 233 nm confirming the 
presence of intercalated CHX into the Carbopol nanogel 
particles. The presence of PDAC was not possible to detect from 
the FTIR spectra of the PDAC-coated CLC as the PDAC it is in 
negligible amount (Figure 3D). There are no characteristic peaks 
from PDAC on the FTIR spectrum of the PDAC-coated CLC. 
However, the zeta-potential measurements confirm its 
presence as it reverses from negative for CLC to positive (Figure 
2E) upon coating with PDAC. 
Elemental (CHN) analysis of CLC 
Table 1 shows the wt% of C, H and N for Carbopol Aqua SF1 and 
CHX-loaded in Carbopol Aqua SF1 (CLC) per dry weight. The 
percentage of encapsulated CHX can vary depending on the 
initial CHX concentration used during the encapsulation process 
with the Carbopol nanogel. CHN-analysis data showed that the 
percentage of CHX into the CLC was about 13.2 wt% (per dry 
weight of CLC). The mole ratio of COOH-group (in Carbopol) to 
CHX was found to be about 50. In this estimate we have 
assumed that the Carbopol composition corresponds to 
polyacrylic acid. This explains why the CHX-loaded Carbopol 
(CLC) particles still carry negative surface charge (negative zeta 
potential) which is due to the dominance of the nanogel COOH 
groups over the positive charge brought by the CHX. 
Table 1.  The elemental analysis of Carbopol Aqua SF1 and the encapsulated 
chlorhexidine (CHX) into Carbopol Aqua SF1 microgel through centrifuging and 
drying the each sample in air at room temperature. 
Element % in Carbopol Aqua SF1  % in CLC 
C 56.73 53.59 
H 4.99 7.35 
N 0.00 3.67 
The % drug content in Carbopol Aqua SF1 
Mole Ratio (COOH /CHX) 
13.2 
50.2  
Release kinetics of CHX from CLC 
Our CHX release experiments done under sink conditions 
showed that the CLC nanogel particles can slowly release free 
CHX upon multiple dilution with water (see Figure 3G) over the 
course of 24 hours. The CHX release rate from the nanogel 
depends on the pH of the surrounding medium. At pH 5.5, 
approximately 13% of the encapsulated CHX was released after 
2 hours while 17% of the total encapsulated amount was 
released after 5 hours. At pH 7.5, 20% of the CHX was released 
out of the nanogel after 2 hours and 25% after 5 hours. The 
sustained release of CHX from the nanogel particles could be 
beneficial in many antimicrobial applications where CHX 
concentration has to be supported in the surrounding media for 
a long period of time. The higher rate of release of CHX at the 
higher pH can be explained by the partial swelling of the 
nanogel which facilitates the CHX diffusion and intercalation 
within the particles interior.  
 
 Materials Chemistry Frontiers   ARTICLE 
This journal is © The Royal Society of Chemistry 2018 Mater. Chem. Front., 2018, 00, 1-3 | 9 
 
 
 
 
Figure 7. (A) The viability of S. cerevisiae cells after exposure to different antimicrobial formulations in Milli-Q water for several incubation times (0, 1, 2 hours). The graph compares 
the anti-yeast activity of 0.005 wt% PDAC, 0.005 wt% PDAC coated Carbopol Aqua SF1 nanogel, 0.1 wt% CHX, 0.1 wt% CLC and 0.005 wt% PDAC-coated 0.1 wt% CLC. (B) The viability 
of S. cerevisiae cells after exposure to formulations of PDAC-coated CLC at different concentrations for various incubation times (0, 1, 2 hours). The solutions are prepared by gradual 
dilution of a stock of 0.005 wt% PDAC-coated 0.1 wt% CHX loaded in 0.1 wt% Carbopol (CLC). The yeast cell viability was tested with FDA live/dead assay in a cell counter. 
Toxicity assay of the non-coated Carbopol nanogel particles 
Two test microorganisms, C. reinhardtii (microalgae) and E. coli, 
were incubated with Carbopol Aqua SF1 suspensions of 
different concentrations of nanogel particles. The cells were 
removed from the culture media to avoid any interaction 
between the nanogel particles and the components of culture 
media. The morphology of C. reinhardtii after incubation with 
the nanogel was studied by TEM. Figure 4B shows TEM images 
of sectioned microalgae cells after incubation for 24 hours with 
0.1 wt% Carbopol nanogel at pH 5.5. The cell wall and the 
internal microstructure the Carbopol nanogel-treated 
microalgae do not indicate visible disruption compared with the 
control microalgae (Figure 4A). Cell viability assay (Figure 4C) 
does not indicate any cytotoxic effect of the non-loaded 
Carbopol Aqua SF1 on C. reinhardtii for a wide range of Carbopol 
Aqua SF1 concentrations at room temperature and up to 6 
hours of incubation. Figure 4D also shows no pronounced 
cytotoxic effect of the Carbopol nanogel on E. coli cells for up to 
24 hours. Similar results (not presented here) were also 
obtained for S. cerevisiae. These data are in agreement with the 
manufacturer’s technical data for other microorganisms.31  
Effect of PDAC-functionalization on Carbopol nanogel stability and 
toxicity 
Figure 5A shows the average particle hydrodynamic diameter of 
the PDAC-coated Carbopol Aqua SF1 nanogels as a function of 
the PDAC-concentration. PDAC- coated Carbopol particles show 
good colloidal stability up to 0.03 wt% PDAC with zeta-
potentials ranging from +12 mV for 0.017 wt% PDAC to +44 mV 
for 0.1 wt% PDAC at pH 5.5. This result shows that upon coating 
with PDAC, the surface charge of the Carbopol nanocarrier has 
changed from negative (bare Carbopol) to positive giving 
cationic particles. We measured the zeta-potential of 0.005% 
PDAC-coated 0.1% carbopol over an interval of over 24 hours 
and did not find any measurable change, as it stayed around 
+252 mV at pH 5.5 (see Figure 2D). Figures 5B and 5C show the 
FDA viability assay for C. reinhardtii and E .coli upon incubation 
with the PDAC-coated nanogel without CHX. One can see that 
the nanocarrier shows measurable toxicity above 0.009 wt% 
PDAC for C. reinhardtii and above 0.018 wt% for E .coli. In order 
to distinguish between the toxicity of the PDAC-coating and the 
antimicrobial action of the CHX, we chose to work at 
concentrations of 0.005 wt% PDAC for which the “empty” 
nanocarrier is non-toxic to both microorganisms. Therefore, any 
further manifestation of antimicrobial action of 0.005 wt% 
PDAC-coated CLC would be solely due to delivery of CHX rather 
than effect of the PDAC coating of the nanocarrier. 
Anti-algal action of PDAC-coated CLC on C. reinhardtii 
The antimicrobial activity of CHX with C. reinhardtii was 
examined by incubation of the microalgae cells for up to 2 hours 
in PDAC-coated CHX-loaded Carbopol nanogel suspensions of 
different concentrations. Figures 6B and 6C shows SEM images 
of C.reinhardtii cells which have been incubated with a 
suspension of 0.005 wt% PDAC-0.0225 wt% CHX-0.1 wt% 
Carbopol for 1 hour. The SEM image in Figure 6A shows the 
morphology of the control sample of untreated microalgae. One 
can see that the cationic nanogel particles have accumulated on 
the cell wall of the treated microalgae. Figure 6C shows a high 
magnification SEM image which visualises the hetero-
coagulation of the CHX-loaded nanocarrier on the cells.  
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Figure 8.  SEM images of E. coli cells after incubation in a suspension of PDAC-coated CLC for 2 hours at room temperature suspension. (A) The control sample of non-treated E. coli, 
(B) and (C) E. coli samples after treatment. (D) The viability of E. coli cells after timed exposure to antimicrobial formulations of PDAC-coated CLC at different concentrations for 
various time points (0, 1, 2 hours). The solutions were prepared by gradual dilution of a stock of 0.005 wt% PDAC-coated 0.1 wt% CHX loaded in 0.1 wt% Carbopol (CLC). (E) The 
viability of E. coli cells after exposure to various antimicrobial formulations in Milli-Q water for various time points (0, 1, 2 hours). The graph compares the antibacterial activity of 
0.005 wt% PDAC, 0.005 wt% PDAC coated Carbopol Aqua SF1 nanogel, 0.1 wt% CHX, 0.1 wt% CLC (without PDAC coating) and 0.005 wt% PDAC-coated 0.1 wt% CLC. The bacterial 
cell viability was tested with Promega CellTiter-Glo® assay. 
This clustering and accumulation of particles is attributed to the 
attraction between the PDAC-functionalised nanogel particle 
and anionic surface of the cells. As a result, the local release of 
CHX from the nanocarrier directly onto the cell membrane 
appears to increase its anti-algal action. Figure 6D shows the 
concentration dependence of the PDAC-coated CLC on the 
microalgae cell viability. The cells were incubated in a series of 
suspension obtained by multiple dilution of a stock suspension 
of 0.005 wt% PDAC-coated 0.1 wt% CHX-loaded 0.1 wt% 
Carbopol nanogel suspension. It can be seen that the CHX 
nanocarrier formulation containing a toxicity threshold 
concentration of 0.077 wt% (or higher) of encapsulated CHX 
reduced the microalgae viability from 90% to 0% after 1 hour of 
incubation. The original stock suspension completely killed the 
microalgae even after 1 hour of incubation and was able to 
reduce the microalgae viability from 90% to less than 20% even 
upon instant treatment (<5 min).  
We also compared the efficiency of the PDAC-coated CLC with 
the equivalent concentrations of free CHX, non-coated CLC with 
the same concentration of CHX as well as the 0.005 wt% PDAC-
coated nanocarrier without CHX and an equivalent 
concentration of free PDAC (0.005 wt%). The microalgae cell 
viability for all these samples and controls after up to 2 hours of 
incubation are compared with the viability of the untreated cells 
in Figure 6E. One sees that although free PDAC on its own has 
significant toxicity against the microalgae, the PDAC-coated 
nanocarrier (without CHX) does not show measurable toxicity 
when compared with the untreated control sample over the 
course of the experiment. Moreover, the results show that free 
CHX is more efficient in its anti-algal action comparted with 
equivalent amount of CLC. This can be explained by the fact that 
the CLC particles are negatively charged (Figure 2E) in the 
aqueous media and are electrostatically repelled from the 
negatively charged cell walls. However, the PDAC-coated CLC is 
not only more efficient than the non-coated CLC with the same 
amount of CHX but also it is also several times more effective 
than the treatment with the equivalent concentration of free 
CHX. This occurs because of the electrostatic attraction 
between the cationic PDAC-coated CLC and the anionic cell 
membrane of the microalgae which allows the released CHX to 
disrupt locally the cell membrane causing the cell death.  
Anti-yeast activity of PDAC-coated CLC on S. cerevisiae  
We tested the action of PDAC-coated CLC towards yeast cells. 
Figure 7A compares the yeast cells viability upon incubation for 
up to 2 hours with PDAC-coated CLC with equivalent 
concentration of free CHX, non-coated CLC with the same 
concentration of CHX as well as the 0.005 wt% PDAC-coated 
nanocarrier (without CHX) and the equivalent concentration of 
free PDAC (at 0.005 wt%). The results show that non-coated CLC 
is much less efficient than free CHX at the same concentration, 
which again is explained by  the electrostatic repulsion between 
the yeast cell surface and negatively charged CLC particles, 
combined with the relatively slow release of CHX in the 
environment (cf. Figure3F). One can also see from this 
comparison that the yeast cells are completely unaffected by 
the PDAC-coated Carbopol nanocarrier (without CHX), although 
it has significant loss of viability in the presence of free PDAC at 
the same concentration.  
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Figure 9. Time kill assay for chlorhexidine and 0.005 wt% PDAC-coated 0.1 wt% CHX 
loaded in 0.1 wt% Carbopol (CLC), 0.005 wt% free PDAC and 0.005 wt% PDAC-coated 
0.1% Carbopol (empty nanocarrier) tested against S. aureus.  The results are presented 
as means ± SD (n = 3). Some of the error bars are within the symbol size. The lines are 
guides to the eye. 
 
PDAC is a very efficient antimicrobial agent as it is a cationic 
polymer which tends to disturb the cell walls even at very low 
concentrations. However, PDAC-coated CLC showed much 
higher anti-yeast efficiency that free CHX and CLC at the same 
equivalent CHX concentration. The explanation for this 
enhanced antimicrobial effect is related to the 
heterocoagulation of the positively charged PDAC-coated CLC 
on to the negatively charged cell walls which boosts the local 
CHX concentration directly on the yeast cells surface. 
Comparing Figure 6D with Figure 7A one can see that under the 
same condition the PDAC-coated CLC is more efficient against 
the microalgae than against yeast, which can be attributed to 
the much thicker cell wall of the yeast cells. In both cases of 
yeast and microalgae we observe a better antimicrobial action 
of the PDAC-coated CLC than free CHX and non-coated CLC. 
Figure 7B shows the concentration dependence of the anti-
yeast action for a stock suspension of 0.005 wt% PDAC-coated 
0.1 wt% CHX – loaded in 0.1% Carbopol. The yeast cell viability 
was measured after up to 2 hours of incubation in solutions 
obtained by multiple dilution of this stock suspension of PDAC-
coated CLC particles. The yeast cell viability can be seen to have 
reduced from 85% to less than 5% after 2 hours of incubation in 
the stock suspension, compared with 77% viability for the 
untreated yeast. The comparison of Figure 7B with Figure 6D 
also confirms that yeast is more resistant towards the PDAC-
coated CLC than the microalgae.  
Anti-bacterial action of PDAC-coated CLC on E. coli 
The antibacterial activity of PDAC-coated CLC with E.coli was 
investigated by incubation for up to 2 hours at room 
temperature with a fixed amount of E.coli cells removed from 
their culture media. Representative SEM images of the control 
sample of untreated E.coli are shown in Figure 8A, compared 
with E. coli samples treated with PDAC-coated CLC (Figures 8B 
and 8C). One can see that as with the microalgae (Figure 6B and 
6C), the E.coli cells have become densely coated with the PDAC-
functionalised CLC nanoparticles after exposure to the 
nanocarrier suspension. The result of this accumulation of the 
CHX-delivery vehicle on the cell viability was assessed in Figure 
8D for various concentrations of the PDAC-coated CLC, obtained 
by gradual dilution of the stock of 0.005 wt% PDAC-coated 0.1 
wt% CHX – loaded in 0.1% Carbopol.  
It should be noted that the threshold of toxicity of the PDAC-
coated CLC against E.coli is significantly lower than the one for 
yeast (cf. Figure 7B) but it is higher than for microalgae (cf. 
Figure 6D). Figure 8E compares the E.coli cells viability upon 
incubation with PDAC-coated CLC and solutions with equivalent 
concentration of free CHX, non-coated CLC with the same 
concentration of CHX, 0.005 wt% PDAC-coated “empty” 
Carbopol nanocarrier and free PDAC at the same concentration 
(0.005 wt%). A very similar picture emerges from this 
comparison, as the equivalent results with microalgae (Figure 
6E) and yeast (Figure 7A). The PDAC-coated CLC shows much 
higher antibacterial efficiency against E.coli than both free CHX 
and non-coated CLC at the same equivalent concentration of 
CHX. Again, the empty PDAC-coated nanocarrier is benign for 
E.coli, i.e. the coating alone does not contribute to any loss of 
E.coli cell viability. 
Antibacterial action of PDAC-coated CLC on S. aureus 
We determined the MIC and MBC of free CHX and PDAC-coated 
CLC on S. aureus as a common bacterial culture found in isolates 
from hospital acquired infected wounds. We found that at the 
same conditions the MIC of the PDAC-coated CLC is 2 times 
lower than this of free CHX. The MBC of the PDAC-coated CLC is 
about 8 times lower than that of free CHX (see Table 2). These 
results illustrate the effect of the nano-encapsulation of the 
CHX into the Carbopol carrier and the targeted delivery of this 
antimicrobial agent directly on the surface for S. aureus, which 
requires several times lower overall CHX concentration to 
achieve the same effect as with free CHX. The advantages of this 
enhancement of the CHX antibacterial action is several fold. This 
means that the same level of bacterial growth inhibition can 
achieved with 2 times lower CHX concentration and 8 lower 
minimal concentration of CHX encapsulated in CLC is needed for 
bactericidal action. Lowering the antimicrobial agent 
concentration is both cases can be beneficial from the point of 
view of economy of active material and lowering the overall side 
toxicity of the antibacterial formulation. This can be beneficial 
to reduce development of future bacterial resistance. Similar is 
the amplification effect of the PDAC-coated CLC on E. coli, C. 
reinhardtii, and S. cerevisiae compared with free CHX (Table 2). 
We also performed a comparative time kill assay on S. aureus 
using the same formulations of free CHX and PDAC-coated CLC 
at the same overall concentration of CHX. The result is 
presented on Figure 9 along with the control of untreated 
bacteria. One sees that the PDAC-coated CLC has practically 
achieves >5 log reduction within 3 hours while the formulation 
based on free CHX has only time-limited effect on the growth of 
S. aureus. 
 
 
ARTICLE Materials Chemistry Frontiers 
12 | Mater. Chem. Front., 2018, 00, 1-3 This journal is © The Royal Society of Chemistry 2018 
 
 
 
Table 2. Minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC) of free CHX and PDAC-coated CLC against S. aureus, E. 
coli, C. reinhardtii, and S. cerevisiae.  The lowest concentration of antimicrobial agent inhibiting/no growth was considered the MIC/MBC/MFC. 
 CHX                       PDAC-coated CLC 
 MIC MBC MIC MBC 
S. aureus 2.5 μL/mL 
(0.05 wt%) 
10 μL/mL 
(0.2 wt%) 
1.25 μL/mL 
(0.025 wt%) 
1.25 μL/mL 
(0.025 wt%) 
E. coli 5 μL/mL 
(0.1 wt%) 
20 μL/mL 
(0.4 wt%) 
2.5 μL/mL 
(0.05 wt%) 
2.5 μL/mL 
(0.05 wt%) 
C. reinhardtii 5 μL/mL 
(0.1 wt%) 
5 μL/mL 
(0.1 wt%) 
0.625 μL/mL 
(0.0125 wt%) 
0.625 μL/mL 
(0.0125 wt%) 
C. cerevisiae 5 μL/mL 
(0.1 wt%) 
10 μL/mL 
(0.2 wt%) 
1.25 μL/mL 
(0.025 wt%) 
2.5 μL/mL 
(0.05 wt%) 
Conclusions 
We have developed a novel surface functionalized nanocarrier 
for chlorhexidine based on lightly cross-linked acrylate 
copolymer nanogel particles (Carbopol Aqua SF1). This 
nanocarrier was surface-functionalised by coating with the 
cationic polyelectrolyte PDAC and showed a strong 
enhancement of the chlorhexidine antimicrobial action. We 
explored the effect of these CHX-loaded nanocarrier on C. 
reinhardtii microalgae, S. cerevisiae and E. coli for CHX-loaded 
nanogel (CLC) with and without coating with the cationic 
polyelectrolyte (PDAC-coated CLC).  We demonstrated that the 
cationic coating of the nanogel strongly amplifies the 
antimicrobial action of the loaded CHX against both C. 
reinhardtii, S. cerevisiae and E. coli even for short incubation 
times. The boost of the CHX antimicrobial activity was 
attributed to the favourable electrostatic attraction between 
the positively charged PDAC-coated CLC and the negatively 
charged cell membranes which leads to their attachment on the 
microbial cell walls where they release locally of highly 
concentrated CHX causing the cell death. SEM images of 
nanocarrier-treated cells showed the preferential deposition of 
the PDAC-coated CLC onto the cell membranes of all studied 
microbial cells. This type of very efficient cationic surface-
functionalised nanogel carriers can be potentially applied to 
boost the antimicrobial action for a range of low-molecular 
weight cationic anti-fungal and anti-algal agents. Similar 
strategy could also find applications for enhancing the action of 
topical antibiotics and antifungal agents and may be used across 
different therapies to bypass antimicrobial resistance. 
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